You are here

V116

Merck gets shot in the arm with FDA approval for first pneumococcal vaccine designed for adults

Fierce Pharma

Mon, 06/17/24 - 10:37 pm

pneumococcal disease

On doorstep of approval, Merck compares V116 pneumococcal vaccine to 1983 warhorse Pneumovax 23

Fierce Biotech

Mon, 04/29/24 - 10:50 pm

pneumococcal disease

FDA accepts Merck’s pneumococcal vaccine BLA for priority review

Pharmaceutical Technology

Wed, 12/20/23 - 09:34 am

pneumococcal disease

Merck strides onto Pfizer’s turf, posting pivotal vaccine data and heading to regulators

Fierce Pharma

Tue, 11/28/23 - 11:52 am

clinical trials

pneumococcal disease

Merck’s next-gen pneumococcal vaccine strides forward after two phase 3 wins

Fierce Biotech

Thu, 07/27/23 - 11:38 am

pneumococcal disease

clinical trials

Merck wins breakthrough therapy designation for potential pneumococcal vaccine successor

Endpoints

Thu, 04/14/22 - 10:43 am

pneumococcal disease